Kaiser Study Backs Cxbladder Triage Ahead of Medicare Panel

"The study publication provides powerful, independent confirmation of Cxbladder's value in daily clinical practice. That is a compelling message for payers, providers, and most importantly, for patients who may otherwise face an invasive procedure they do not need." said Pacific Edge CEO Dr Meintjes Post this This publication comes at an important time for Pacific Edge, because peer-reviewed publications can be considered by the Contractor Advisory Committee (CAC) that Novitas, our Medicare Administrative ...